SION
Sionna Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.01
+3.08%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.64
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.66
- EPS estimate
- -$0.65
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -124.6%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $33
- PT range
- $6.00 – $60
- Analysts
- 5
0 Buy5 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.65 | -$0.66 | Miss -1.54% | — |
| May 12, 2026 | -$0.52 | -$0.60 | Miss -15.38% | — |
| Nov 5, 2025 | -$0.52 | -$0.46 | Beat 11.54% | — |
| Mar 20, 2025 | -$0.57 | -$3.38 | Miss -492.98% | — |
| Nov 27, 2024 | — | -$0.92 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026